The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Purpose Dual Treatment SPF 10
Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3% · OXYBENZONE 3 g/100g; OCTINOXATE 7.5 g/100g; OCTISALATE 5 g/100g · Lotion · Topical · Elysium Consumer Healthcare LLC
NDC 87033-2000-01 · 1 BOTTLE, PLASTIC in 1 CARTON / 113 g in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3% (Lotion)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Elysium Consumer Healthcare LLC | OXYBENZONE 3 g/100g; OCTINOXATE 7.5 g/100g; OCTISALATE 5 g/100g | Aug 26, 2026 | Sep 2, 2026 |
| Elysium Consumer Healthcare LLC | OXYBENZONE 7.5 g/100g; OCTINOXATE 5 g/100g; OCTISALATE 3 g/100g | Jul 22, 2026 | Aug 19, 2026 |
| Elysium Consumer Healthcare LLC | OCTINOXATE 7.5 g/100g; OCTISALATE 5 g/100g; OXYBENZONE 3 g/100g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Purpose Dual Treatment SPF 10 — NDC 87033-2000-01," retrieved September 3, 2026, https://drugdashboards.com/drug/87033200001.
Free to cite with attribution — see how the data is put together.